source Post navigation Tirzepatide cuts diabetes risk by 94% in SURMOUNT-1 trial – Drug Discovery & Development Clinical Practice Guidelines for Lipid Management in Adult Diabetic Kidney Disease (ABCD-UKKA, 2024) – Medscape Reference